SEMAGLUTIDE 10MG
10mg · 2ml vial · 12 weeks (dose dependent)
Semaglutide is a once-weekly injectable GLP-1 receptor agonist used for sustained weight loss and metabolic improvement. It is the most extensively studied modern GLP-1 medication and the active ingredient in Wegovy and Ozempic.
Semaglutide reduces appetite, slows gastric emptying, and improves insulin sensitivity.
Physical label displays 2.5mg/0.5ml in a 2ml vial size, for a total content of 10mg.
Medical compliance
All medications are physician-prescribed following individual evaluation and dispensed by US-licensed 503A compounding pharmacies. Statements have not been evaluated by the FDA. Information on this page is for educational purposes only and is not a substitute for professional medical advice. Use only under qualified medical supervision.